-
Cotation en bourse
Strengthening Europe’s strategic autonomy through capital marketsCzechoslovak Group lists on EuronextLire la suiteWorld’s largest defence IPO ever recorded.
Learn more about Euronext’s initiatives to enhance financing and visibility for European aerospace and defence companies -
Trading
Where European Government Bonds meet the futureFixed Income derivativesLire la suiteTrade Mini Bond Futures on main European Government Bonds
-
Clearing
Step into Europe’s next phase of Repo ClearingRepo ClearingLire la suiteEuronext is expanding its repo clearing services to boost market access, liquidity provision and collateral optimisation across Europe.
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLire la suiteEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Lire la suiteThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLire la suiteThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
About Euronext
Euronext strategic planInnovate for Growth 2027Lire la suiteShaping capital markets for future generations
Bell Ceremony pour accueillir la semaine européenne de la biotechnologie 2014 à Bruxelles
08/10/2014
Le 8 Octobre2014, Nathalie Moll, secretary general d'EuropaBio et Karin Baudin, Vice-présidente Technology Transfer InsermTransfert de ENTENTE PROJECTont ouvert les marchés européens d'Euronext avec une Bell Ceremony.
Les partenaires duprojet ENTENTE, de la Commission Européenne et d’EuropaBio ont annoncé les 2 événements qui ont lieu pendant la semaine européenne de la biotechnologie notamment la 5ème édition de l’Award « Most Innovative European Biotech SME Award » et« ENTENTE Life Sciences Investment Forum ».
Ruxandra Draghia-Akli, Directrice, Direction Santé, DG Recherche et Innovation,de la CommissionEuropéenne a clôturé la Bell Ceremony avec un discours.
Pour en savoir plus : www.biotechweek.org